SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Bluegreen who wrote (9404)3/29/1999 11:59:00 AM
From: aknahow  Read Replies (1) | Respond to of 17367
 
Ellen Martin is "not aware" that the mortality target has ever changed. That is why I was trying to get some focus on how a significant p value can be established with just mortality in both arms. Once they had established the mortality levels they apparently were able to calculate accruals and ESTIMATE how long it would take to get there.

Caution!!! I believe there were times when Martin claimed she was not aware of what the target was. If this is true and correct on my part as well as hers it is possible the target could have changed. She apparently is aware of the current target. By not saying, "NO" she leaves open the possibility that indeed it could have changed.



To: Bluegreen who wrote (9404)3/30/1999 7:44:00 AM
From: Robert K.  Respond to of 17367
 
And consider this link in light of the last link. Combine the two thoughts and consider meningococcemia.
>http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8564523&form=6&db=m&Dopt=b


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News